RBC Capital Maintains Sector Perform on Bristol-Myers Squibb, Raises Price Target to $64

Benzinga Newsdesk www.benzinga.com Positive 90.5%

Neg 0% Neu 0% Pos 90.5%

RBC Capital analyst Trung Huynh maintains Bristol-Myers Squibb (NYSE:BMY) with a Sector Perform and raises the price target from $60 to $64.